Cytotheryx Receives $60 Million Series A Funding for Liver Disease Cell Therapy

Cytotheryx obtains significant financing to advance liver disease cell therapy programs and support operational expansion.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here